Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-20 07:00 am Purchase |
2024-02-20 | 13G | Biofrontera Inc. BFRI |
HIRSCHMAN ORIN | 501,434 9.900% |
501,434 (New Position) |
Filing History |
| 2024-02-21 06:01 am Sale |
2024-02-13 | 13G | BrainsWay Ltd. BWAY |
HIRSCHMAN ORIN | 682,482 4.100% |
-356,046 (-34.28%) |
Filing History |
| 2024-02-13 06:34 am Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
HIRSCHMAN ORIN | 70,583 9.990% |
70,583 (New Position) |
Filing History |
| 2024-02-07 7:16 pm Sale |
2024-02-07 | 13G | Biodesix, Inc. BDSX |
HIRSCHMAN ORIN | 3,408,946 3.800% |
-2,159,955 (-38.79%) |
Filing History |
| 2024-02-07 7:01 pm Sale |
2024-01-30 | 13G | Cognition Therapeutics, Inc. CGTX |
HIRSCHMAN ORIN | 1,448,270 4.800% |
-589,583 (-28.93%) |
Filing History |
| 2024-02-07 6:58 pm Purchase |
2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 2,662,324 8.700% |
747,104 (+39.01%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | LightPath Technologies, Inc. LPTH |
HIRSCHMAN ORIN | 3,723,932 9.900% |
144,100 (+4.03%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
HIRSCHMAN ORIN | 349,300 11.000% |
4,300 (+1.25%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
HIRSCHMAN ORIN | 2,040,540 5.900% |
156,259 (+8.29%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | BK Technologies Corporation BKTI |
HIRSCHMAN ORIN | 330,896 9.600% |
330,896 (New Position) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | BrainsWay Ltd. BWAY |
HIRSCHMAN ORIN | 1,038,528 6.300% |
33,093 (+3.29%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Coya Therapeutics, Inc. COYA |
HIRSCHMAN ORIN | 1,164,372 8.100% |
471,977 (+68.17%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | Electrovaya Inc. ELVA |
HIRSCHMAN ORIN | 3,353,308 9.900% |
3,353,308 (New Position) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2024-01-25 | 13G | Elutia Inc. ELUT |
HIRSCHMAN ORIN | 1,886,556 9.900% |
17,026 (+0.91%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | KWESST Micro Systems Inc. KWE |
HIRSCHMAN ORIN | 55,618 9.900% |
15,618 (+39.04%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF |
HIRSCHMAN ORIN | 4,672,075 6.700% |
242,092 (+5.46%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2024-01-16 | 13G | Myomo, Inc. MYO |
HIRSCHMAN ORIN | 2,838,290 9.900% |
298,290 (+11.74%) |
Filing History |
| 2024-02-07 6:55 pm Sale |
2023-12-31 | 13G | Red Cat Holdings, Inc. RCAT |
HIRSCHMAN ORIN | 5,026,104 7.000% |
-250,000 (-4.74%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 3,106,795 8.700% |
556,561 (+21.82%) |
Filing History |
| 2024-02-07 6:55 pm Purchase |
2024-01-29 | 13G | SmartKem, Inc. SMTK |
HIRSCHMAN ORIN | 136,937 9.900% |
136,937 (New Position) |
Filing History |